TSVT Stock Price | 2Seventy Bio Inc P/E, Revenue, EPS, & Forecasts

2Seventy Bio Inc • TSVT

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About 2Seventy Bio Inc

Ticker

TSVT

Trading on

NASDAQ

ISIN

US9013841070

Industry

Biotechnology

Sector

Healthcare

CEO

William D. Baird III, M.B.A.

Headquarters

60 Binney Street, Cambridge, MA, United States, 02142

Employees

274

Website

2seventybio.com

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Metrics

BasicAdvanced

Market cap

$259M

P/E ratio

EPS

-$1.83

Dividend Yield

0.00%

Beta

1.74

Forward P/E ratio

EBIDTA

$-98.4M

Ex dividend date

Price & volume

Market cap

$259M

Average daily volume

2.3M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

6.85

Price to book

1.13

Earnings

EPS

-$1.83

EPS estimate (current quarter)

-$0.24

EPS estimate (next quarter)

-$0.18

EBITDA

$-98.4M

Revenues (TTM)

$37.9M

Revenues per share (TTM)

$0.73

Technicals

Beta

1.74

52-week High

$5.99

52-week Low

$2.29

50-day moving average

$3.09

200-day moving average

$3.92

Short ratio

1.45

Short %

7.65%

Management effectiveness

ROE (TTM)

24.56%

ROA (TTM)

12.63%

Profit margin

151.20%

Gross profit margin

$15.3M

Operating margin

789.27%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

72.60%

Share stats

Outstanding Shares

52.3M

Float

43.8M

Insiders %

6.59%

Institutions %

85.11%

Analyst Insights & forecasts

40% Buy

40% Hold

20% Sell

Based on information from 5 analysts.

Average price target

$5.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$1.11

-$0.99

12.12%

Q4 • 23Beat

-$1.01

-$0.81

24.69%

Q1 • 24Beat

$0.45

-$0.65

169.23%

Q2 • 24Beat

-$0.19

-$0.24

20.79%

Q3 • 24Beat

-$0.31

-$0.10

206.10%

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$9M

$24.9M

277.45%

Q2 • 24

$13.5M

$-9.9M

73.39%

Q3 • 24

50.93%

139.93%

126.45%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$518M

$283M

54.66%

Q2 • 24

$504M

$276M

54.73%

Q3 • 24

2.71%

2.60%

0.12%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-23.1M

$78.4M

$-0M

$-23.2M

Q2 • 24

$-10.5M

$-41.5M

$0.1M

$-10.5M

Q3 • 24

54.61%

152.90%

316.67%

54.58%

QoQ growth

QuarterlyAnnual

Sentiment analysis

-1.5

Greed

+1.5

0.38

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a 2Seventy Bio Inc share?

2Seventy Bio Inc shares are currently traded for undefined per share.

How many shares does 2Seventy Bio Inc have?

2Seventy Bio Inc currently has 52.3M shares.

Does 2Seventy Bio Inc pay dividends?

No, 2Seventy Bio Inc doesn't pay dividends.

What is 2Seventy Bio Inc 52 week high?

2Seventy Bio Inc 52 week high is $5.99.

What is 2Seventy Bio Inc 52 week low?

2Seventy Bio Inc 52 week low is $2.29.

What is the 200-day moving average of 2Seventy Bio Inc?

2Seventy Bio Inc 200-day moving average is $3.92.

Who is 2Seventy Bio Inc CEO?

The CEO of 2Seventy Bio Inc is William D. Baird III, M.B.A..

How many employees 2Seventy Bio Inc has?

2Seventy Bio Inc has 274 employees.

What is the market cap of 2Seventy Bio Inc?

The market cap of 2Seventy Bio Inc is $259M.

What is the P/E of 2Seventy Bio Inc?

The current P/E of 2Seventy Bio Inc is null.

What is the EPS of 2Seventy Bio Inc?

The EPS of 2Seventy Bio Inc is -$1.83.

What is the PEG Ratio of 2Seventy Bio Inc?

The PEG Ratio of 2Seventy Bio Inc is null.

What do analysts say about 2Seventy Bio Inc?

According to the analysts 2Seventy Bio Inc is considered a buy.